TAYSHA GENE THERAPIES INC shareholders Q4 2022

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 53 filers reported holding TAYSHA GENE THERAPIES INC in Q4 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

TAYSHA GENE THERAPIES INC shareholders Q4 2022
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 724,873$1,6380.45%
Quantum Private Wealth, LLC 313,457$708,4130.45%
Nantahala Capital Management 2,999,765$6,779,4690.44%
Altium Capital Management LP 359,051$811,4550.41%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 1,500,000$3,390,0000.34%
Artal Group S.A. 1,440,882$3,2560.18%
Redwood Wealth Management Group, LLC 35,600$80,4560.10%
CARLSON CAPITAL L P 560,000$1,265,6000.10%
Alphabet Inc. 640,882$1,448,3930.08%
GSA CAPITAL PARTNERS LLP 183,857$4160.05%
Sargent Investment Group, LLC 42,987$97,1510.03%
CORNERCAP INVESTMENT COUNSEL INC 55,359$125,1110.02%
Laurion Capital Management LP 1,292,600$2,921,2760.01%
Bordeaux Wealth Advisors LLC 10,000$22,6000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 104,869$237,0040.01%
CAAS CAPITAL MANAGEMENT LP 22,994$51,9660.00%
ACADIAN ASSET MANAGEMENT LLC 261,851$5900.00%
Renaissance Technologies 519,800$1,1750.00%
Jump Financial, LLC 16,917$38,2320.00%
Quantbot Technologies LP 9,729$21,9880.00%
External links

This page lists TAYSHA GENE THERAPIES INC's shareholders in Q4 2022. To view TAYSHA GENE THERAPIES INC's shareholder history, click here.